Oral cancer is a deadly disease. One North American dies every hour of every day of oral cancer. The disease claims over twice as many lives as cervical cancer.
The VELSCOPE SYSTEM is the first adjunctive devise cleared by the FDA to help dentists, hygienist, and other health professionals to see cancerous and precancerous lesions that might not be visible to the naked eye.
Supplementing this new technology with a standard visual exam greatly enhances our ability to detect abnormal lesions in the earliest stages when the prognosis is much more favorable for the patient.